title: Dynamical and structural analysis of a T cell survival network identifies novel candidate therapeutic targets for large granular lymphocyte leukemia.
abstract: The blood cancer T cell large granular lymphocyte (T-LGL) leukemia is a chronic disease characterized by a clonal proliferation of cytotoxic T cells. As no curative therapy is yet known for this disease, identification of potential therapeutic targets is of immense importance. In this paper, we perform a comprehensive dynamical and structural analysis of a network model of this disease. By employing a network reduction technique, we identify the stationary states (fixed points) of the system, representing normal and diseased (T-LGL) behavior, and analyze their precursor states (basins of attraction) using an asynchronous Boolean dynamic framework. This analysis identifies the T-LGL states of 54 components of the network, out of which 36 (67%) are corroborated by previous experimental evidence and the rest are novel predictions. We further test and validate one of these newly identified states experimentally. Specifically, we verify the prediction that the node SMAD is over-active in leukemic T-LGL by demonstrating the predominant phosphorylation of the SMAD family members Smad2 and Smad3. Our systematic perturbation analysis using dynamical and structural methods leads to the identification of 19 potential therapeutic targets, 68% of which are corroborated by experimental evidence. The novel therapeutic targets provide valuable guidance for wet-bench experiments. In addition, we successfully identify two new candidates for engineering long-lived T cells necessary for the delivery of virus and cancer vaccines. Overall, this study provides a bird's-eye-view of the avenues available for identification of therapeutic targets for similar diseases through perturbation of the underlying signal transduction network.
authors.affiliation: Department of Mathematics, The Pennsylvania State University, University Park, United States of America.
authors.forename: Assieh
authors.initials: A
authors.lastname: Saadatpour
authors.forename: Rui-Sheng
authors.initials: RS
authors.lastname: Wang
authors.forename: Aijun
authors.initials: A
authors.lastname: Liao
authors.forename: Xin
authors.initials: X
authors.lastname: Liu
authors.forename: Thomas P
authors.initials: TP
authors.lastname: Loughran
authors.forename: István
authors.initials: I
authors.lastname: Albert
authors.forename: Réka
authors.initials: R
authors.lastname: Albert
mesh_terms: D002470:Cell Survival / Q000276:immunology; D006801:Humans; D054066:Leukemia, Large Granular Lymphocytic / Q000276:immunology* / Q000378:metabolism*; D010766:Phosphorylation; D015398:Signal Transduction; D051899:Smad2 Protein / Q000378:metabolism; D051900:Smad3 Protein / Q000378:metabolism; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000378:metabolism*
chemical_list: C497782:SMAD2 protein, human; C497790:SMAD3 protein, human; D051899:Smad2 Protein; D051900:Smad3 Protein
references.citation: Blood. 2008 Aug 1;112(3):770-81
references.pmid: 18477771
references.citation: FEBS Lett. 2005 Aug 29;579(21):4642-6
references.pmid: 16095595
references.citation: Oncogene. 2004 Dec 9;23(57):9220-9
references.pmid: 15516985
references.citation: BMC Syst Biol. 2008 Nov 24;2:99
references.pmid: 19025648
references.citation: Biochim Biophys Acta. 2008 Apr;1782(4):197-228
references.pmid: 18313409
references.citation: PLoS Comput Biol. 2010 Jul 08;6(7):e1000842
references.pmid: 20628620
references.citation: BMC Bioinformatics. 2006 Feb 07;7:56
references.pmid: 16464248
references.citation: J Theor Biol. 2005 Aug 7;235(3):431-49
references.pmid: 15882705
references.citation: Blood. 2002 Aug 15;100(4):1449-53
references.pmid: 12149230
references.citation: Sci Signal. 2008 Oct 21;1(42):ra10
references.pmid: 18941139
references.citation: Source Code Biol Med. 2008 Nov 14;3:16
references.pmid: 19014577
references.citation: Bioinformatics. 2008 Sep 1;24(17):1917-25
references.pmid: 18614585
references.citation: Science. 2004 Jan 23;303(5657):540-3
references.pmid: 14704431
references.citation: J Theor Biol. 2011 Nov 21;289:167-72
references.pmid: 21907211
references.citation: Methods Enzymol. 2009;467:281-306
references.pmid: 19897097
references.citation: Immunol Rev. 2003 Apr;192:143-60
references.pmid: 12670402
references.citation: Science. 2002 Oct 25;298(5594):799-804
references.pmid: 12399584
references.citation: Curr Vasc Pharmacol. 2008 Oct;6(4):301-12
references.pmid: 18855718
references.citation: Clin Lymphoma Myeloma. 2009;9 Suppl 3:S244-53
references.pmid: 19778848
references.citation: Nat Rev Cancer. 2010 Jun;10(6):415-24
references.pmid: 20495575
references.citation: Blood. 1990 Feb 15;75(4):935-40
references.pmid: 2302461
references.citation: Cell. 2003 Jun 13;113(6):685-700
references.pmid: 12809600
references.citation: Bioinformatics. 2008 Jan 15;24(2):293-5
references.pmid: 18033793
references.citation: Blood. 1997 Jan 1;89(1):201-11
references.pmid: 8978293
references.citation: Blood. 2010 Jan 7;115(1):51-60
references.pmid: 19880494
references.citation: PLoS Comput Biol. 2007 Aug;3(8):e163
references.pmid: 17722974
references.citation: PLoS Comput Biol. 2010 Jul 08;6(7):e1000851
references.pmid: 20628618
references.citation: Curr Rheumatol Rep. 2009 Oct;11(5):378-85
references.pmid: 19772834
references.citation: Int J Oncol. 2003 Jan;22(1):33-9
references.pmid: 12469182
references.citation: Nature. 2002 Nov 14;420(6912):190-3
references.pmid: 12432396
references.citation: Blood. 1993 Jul 1;82(1):1-14
references.pmid: 8324214
references.citation: Blood. 1991 Sep 1;78(5):1282-5
references.pmid: 1831681
references.citation: Cancer Res. 2009 May 1;69(9):3986-94
references.pmid: 19366803
references.citation: Bull Math Biol. 1995 Mar;57(2):247-76
references.pmid: 7703920
references.citation: Int J Oncol. 2005 Feb;26(2):529-35
references.pmid: 15645140
references.citation: Biochim Biophys Acta. 2002 Dec 12;1579(2-3):117-23
references.pmid: 12427546
references.citation: Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16308-13
references.pmid: 18852469
references.citation: Bioinformatics. 2011 Feb 15;27(4):548-55
references.pmid: 21193523
references.citation: Oncologist. 2006 Mar;11(3):263-73
references.pmid: 16549811
references.citation: J Theor Biol. 2009 Sep 21;260(2):196-209
references.pmid: 19524598
references.citation: J Neurosci. 2010 Aug 11;30(32):10734-43
references.pmid: 20702704
references.citation: Blood. 2006 Jun 15;107(12):4834-40
references.pmid: 16484592
references.citation: Bioinformatics. 2006 Jul 15;22(14):e124-31
references.pmid: 16873462
references.citation: Blood. 1998 Dec 15;92(12):4771-7
references.pmid: 9845544
references.citation: PLoS Biol. 2006 Oct;4(10):e312
references.pmid: 16968132
references.citation: Syst Biol (Stevenage). 2006 Jul;153(4):154-67
references.pmid: 16986617
references.citation: J Theor Biol. 1973 Dec;42(3):563-85
references.pmid: 4588055
references.citation: Mol Cancer. 2004 Dec 03;3(1):34
references.pmid: 15575964
references.citation: Blood. 2008 Feb 1;111(3):1610-6
references.pmid: 17993614
references.citation: BMC Syst Biol. 2011 Mar 22;5:44
references.pmid: 21426566
references.citation: BMC Syst Biol. 2007 Jan 08;1:2
references.pmid: 17408509
references.citation: J Theor Biol. 2010 Oct 21;266(4):641-56
references.pmid: 20659480
references.citation: J Theor Biol. 1969 Mar;22(3):437-67
references.pmid: 5803332
references.citation: Nat Rev Mol Cell Biol. 2005 Feb;6(2):99-111
references.pmid: 15654321
references.citation: Curr Opin Cell Biol. 2003 Apr;15(2):221-31
references.pmid: 12648679
references.citation: Biochem Biophys Res Commun. 2010 May 21;396(1):111-5
references.pmid: 20494121
references.citation: J Clin Invest. 2001 Feb;107(3):351-62
references.pmid: 11160159